IL1A and neoplasm: In an oncogene-transformed NIH/3Y3-derived cell line overexpressing cytosolic or membrane-bound forms of IL-1α, IL-1α exerts adjuvant-like effects, increasing the immunogenicity of tumor-cell antigens and regression of the tumor [90].